- POLYMORPHIC FORMS OF (R)-OXYBUTYNIN HYDROCHLORIDE
-
Polymorphic forms of (R)-oxybutynin HC1, including three crystalline forms, are prepared and characterized. Uses of the various polymorphic forms of (R)-oxybutynin HC1 for Obstructive Sleep Apnea (OS A) treatment are also disclosed.
- -
-
Paragraph 0152-0154
(2021/11/13)
-
- SUBSTITUTED PHENYLCYCLOHEXYLGLYCOLATES
-
Disclosed herein are substituted phenylcyclohexylglycolate-based muscarinic acetylcholine receptor modulators of Formula I, processes of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
- -
-
Page/Page column 53-54
(2009/10/06)
-
- CRYSTALLINE OXYBUTYNIN AND PROCESS FOR PREPARING THE SAME
-
The present invention relates to a crystalline oxybutynin base and process for preparing the same. Further, this invention discloses a process for preparing an acid addition salt of oxybutynin employing the crystalline oxybutynin base.
- -
-
Page/Page column 7
(2009/10/30)
-
- BIOSYNCHRONOUS TRANSDERMAL DRUG DELIVERY
-
Systems and methods for treating diseases, addictions and disorders in humans and animals involving synchronizing and tailoring the administration of drug compounds with the body's natural circadian rhythms, in order to counteract symptoms when they are likely to be at their worst. Automated and pre programmable transdermal drug administration system are used. This system can also utilize a pump or pressurized reservoir, and/or a system for removing depleted carrier solution, or other modulated dispensing actuator, in conjunction with micro-fabricated structures commonly referred to as Micro-needles, or heat, or iontophoresis, sonophoresis, or a wide range of chemical permeation enhancers.
- -
-
-
- QUATERNARY AMMONIUM COMPOUNDS
-
The invention features quaternary ammonium compounds of formula I, described herein, and their use in treating asthma, chronic obstructive pulmonary disorder, allergic rhinitis, and infectious rhinitis.
- -
-
-